Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
Authors
Keywords
-
Journal
eLife
Volume 6, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2017-01-16
DOI
10.7554/elife.21253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
- (2016) K T Siu et al. LEUKEMIA
- BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
- (2016) I. A. Asangani et al. MOLECULAR CANCER RESEARCH
- The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
- (2016) H. K. Bid et al. MOLECULAR CANCER THERAPEUTICS
- Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
- (2016) Shaokun Shu et al. NATURE
- Managing risks in drug discovery: reproducibility of published findings
- (2016) Aimo Kannt et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
- (2016) L L da Motta et al. ONCOGENE
- Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice
- (2016) Dong U. Lee et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
- (2016) A. Stathis et al. Cancer Discovery
- BET inhibition as a new strategy for the treatment of gastric cancer
- (2016) Raquel C. Montenegro et al. Oncotarget
- Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function
- (2016) Andre Kleensang et al. Scientific Reports
- BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
- (2016) Saeed Alghamdi et al. Stem Cell Research & Therapy
- BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
- (2016) Zhenfeng Zhang et al. Theranostics
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
- (2016) Sandy Amorim et al. Lancet Haematology
- Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
- (2015) Philipp Rathert et al. NATURE
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition
- (2015) Weilong Yao et al. Oncotarget
- GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1
- (2015) Krishan Kumar et al. Scientific Reports
- Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
- (2015) Irawati Kandela et al. eLife
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Pyk2 promotes tumor progression in multiple myeloma
- (2014) Y. Zhang et al. BLOOD
- Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives
- (2014) Robert F. Shearer et al. GENES TO CELLS
- Standardised animal models of host microbial mutualism
- (2014) A J Macpherson et al. Mucosal Immunology
- An open investigation of the reproducibility of cancer biology research
- (2014) Timothy M Errington et al. eLife
- Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
- (2013) A. Chaidos et al. BLOOD
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature
- (2013) K. M. Kokolus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo
- (2012) T. D. Laajala et al. CLINICAL CANCER RESEARCH
- Replicates and repeats—what is the difference and is it significant?
- (2012) David L Vaux et al. EMBO REPORTS
- Inhibition of Firefly Luciferase by General Anesthetics: Effect on In Vitro and In Vivo Bioluminescence Imaging
- (2012) Marleen Keyaerts et al. PLoS One
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals
- (2010) Dan M. Close et al. SENSORS
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and repeatability of photon emission
- (2008) Marleen Keyaerts et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started